Cargando…
Soluble TREM-1 plasma concentration predicts poor outcome in COVID-19 patients
BACKGROUND: The immuno-receptor Triggering Expressed on Myeloid cells-1 (TREM-1) is activated during bacterial infectious diseases, where it amplifies the inflammatory response. Small studies suggest that TREM-1 could be involved in viral infections, including COVID-19. We here aim to decipher wheth...
Autores principales: | Gibot, Sébastien, Lafon, Thomas, Jacquin, Laurent, Lefevre, Benjamin, Kimmoun, Antoine, Guillaumot, Anne, Losser, Marie-Reine, Douplat, Marion, Argaud, Laurent, De Ciancio, Guillaume, Jolly, Lucie, Touly, Nina, Derive, Marc, Malaplate, Catherine, Luc, Amandine, Baumann, Cédric, François, Bruno |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423708/ https://www.ncbi.nlm.nih.gov/pubmed/37574520 http://dx.doi.org/10.1186/s40635-023-00532-4 |
Ejemplares similares
-
Potentiation of NETs release is novel characteristic of TREM-1 activation and the pharmacological inhibition of TREM-1 could prevent from the deleterious consequences of NETs release in sepsis
por: Boufenzer, Amir, et al.
Publicado: (2021) -
sTREM-1 is a specific biomarker of TREM-1 pathway activation
por: Jolly, Lucie, et al.
Publicado: (2021) -
Urine sTREM-1 assessment in diagnosing sepsis and sepsis-related acute kidney injury
por: Derive, Marc, et al.
Publicado: (2011) -
Soluble TLT-1 is a naturally occurring TREM-1 inhibitor and protects mice from hyperresponsiveness and death during sepsis
por: Derive, M, et al.
Publicado: (2010) -
Role of TREM-1 in endothelial dysfunction during experimental sepsis
por: Boufenzer, A, et al.
Publicado: (2012)